Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study
Clinical trial NCT05602935 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05602935
- Sponsor
- The Second Affiliated Hospital of Fujian Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-16
- Primary completion
- 2022-03-30
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.